Return to Vaccination News Home Page

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Search This Site using keywords

 

http://www.medadnews.com/news/show_article.asp?articleID=85650&catid=30

 

Med Ad NewsPharma Business This MonthR & D Directions This MonthDatabase ProductsCareer OpportunitiesEngel Publishing Partners
Corporate Info CenterIndustry LinksContact UsHome
Pharmaceutical industry news by category occurring in the past 30 days
Business
Marketing and Advertising
Research and Development
 


 

Senator Kay Bailey Hutchison and Senator Edward Kennedy Act to Protect Millions of Americans With Hepatitis C
WASHINGTON, May 23, 2003--Senators Kay Bailey Hutchison and Edward Kennedy today filed The Hepatitis C Epidemic Control and Prevention Act (S-1143), announced the National Hepatitis C Advocacy Council (NHCAC). This is the first federal response to the hepatitis C epidemic, the most common blood-borne viral infection in the United States. An estimated four million Americans are currently infected with the hepatitis C virus (HCV). HCV yearly costs are already at an alarming $15 billion dollars. That figure is expected to skyrocket to $26 billion by 2021.

 

Hepatitis C threatens the health of millions of Americans. NHCAC has worked to educate federal and state governments about the seriousness and magnitude of the hepatitis C epidemic. Approximately 85 percent of those who contract HCV remain infected for life, and an estimated 15,000 die each year. The annual death toll is expected to triple by 2010. There is currently no vaccine to prevent HCV infection.

 

The Hepatitis C Epidemic Control and Prevention Act is groundbreaking legislation. It will establish a comprehensive program for HCV public awareness campaigns, screening and counseling, early detection, professional education, and research. The program will be administered by the Department of Health and Human Services. State and local hepatitis C agencies will be supported to implement program activities.

 

The National Hepatitis C Advocacy Council is comprised of 22 hepatitis C groups from across the United States. NHCAC President Lorren Sandt commented: "This is a major step in achieving a key goal of NHCAC: increasing financial and infrastructure support for the delivery of hepatitis C prevention, education, and patient care services at a level commensurate with the impact of this disease. Chronic hepatitis C is completely preventable with sound public health policy in place."

 

NHCAC Government Affairs Chairperson Sharon Phillips added: "For the first time, we have a bill that will work for the millions of infected Americans. We congratulate Senators Hutchison and Kennedy for taking action now with S-1143 and providing the resources necessary to address this previously unfunded epidemic."

 

Cosponsors of this bipartisan bill include Senators Daschle (D-SD), Biden (D-DE), Smith, (R-OR), Johnson, (D-SD), Bingaman (D-NM), Breaux (D-LA), Campbell (R-CO), Clinton (D-NY), Cornyn (R-TX), Dodd (D-CT), Jeffords (I-VT), and Schumer (D-NY). A companion bill will be introduced in the House in the next few weeks. CONTACT: National Hepatitis C Advocacy Council

 

Lorren Sandt, 877/737-4372

 

Andi Thomas, 954/931-8463

 

Sharon Phillips, 903/235-0408
Return to top



 

 

 

Engel Publishing Partners • 828A Newtown-Yardley Road • Newtown, PA 18940 • Telephone: 215-867-0044
[ Home ] [ Med Ad News ] [ Med Ad News Global ] [ R&D Directions ] [ Database Products ]
[ Advertise on PharmaLive ] [ Site Map ] [ Contact Us ] [ Privacy ] [ Copyright ]
©2003 Engel Publishing Partners

 

 

 

Return to Vaccination News Home Page

DISCLAIMER:    All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice.  The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.